Evidence map›Paper›PMID 42693924›Full record

ArticleBioinformatics (Oxford, England)2026

ABAG-Rank: improving model selection of AlphaFold antibody-antigen complexes by learning to rank.

Matteo Tadiello, Marko Ludaic, Vsevolod Viliuga, Arne Elofsson

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matteo TadielloDepartment of biochemistry and biophysics (DBB) and SciLifeLab, Stockholm University, Stockholm, 171 65, Sweden.ORCID 0000-0002-2201-5129
Marko LudaicDepartment of biochemistry and biophysics (DBB) and SciLifeLab, Stockholm University, Stockholm, 171 65, Sweden.
Vsevolod ViliugaDepartment of biochemistry and biophysics (DBB) and SciLifeLab, Stockholm University, Stockholm, 171 65, Sweden.
Arne ElofssonDepartment of biochemistry and biophysics (DBB) and SciLifeLab, Stockholm University, Stockholm, 171 65, Sweden.ORCID 0000-0002-7115-9751

Funding

Knut and Alice Wallenberg Foundation SNIC 2021/5-297
6 · The paper itself

Abstract

motivationAlphaFold has transformed structural biology with an unprecedented accuracy in modelling protein structures and their interactions with biomolecules, with AlphaFold3 (AF3) achieving state-of-the-art performance. However, AF3 and other methods often struggle to accurately predict the structure of protein complexes that lack strong co-evolutionary information, such as antibody-antigen (Ab-Ag) complexes. One of the fundamental issues is that AF3 often generates accurate predictions, but fails to reliably distinguish them from the much larger set of incorrect ones.

resultsTo address this, we propose ABAG-Rank, a deep neural network that provides an efficient and robust solution for model selection of Ab-Ag interactions from a pool of structural ensembles predicted with AlphaFold. Built on the permutation-invariant DeepSets architecture, ABAG-Rank can process variable-sized ensembles of structural decoys and is directly applicable to prediction settings in which the number of candidates may vary. We train a model on a redundancy-reduced set of all known antibody-antigen complexes and find that simple geometric descriptors, along with confidence scores from AlphaFold, provide rich information about interface quality without requiring intensive physics-based calculations. Our experiments demonstrate that ABAG-Rank significantly outperforms AF3 internal scoring and the ranking performance of existing deep learning baselines. AVAILABILITY AND IMPLEMENTATION: Source code can be found at: https://github.com/tadteo/ABAG-Rank or on Zenodo at https://doi.org/10.5281/zenodo.21132090.

Indexed as

Antigen-Antibody ComplexComputational BiologyDeep LearningNeural Networks, ComputerSoftwareAlgorithmsModels, MolecularProtein ConformationProtein FoldingAntigen-Antibody Complex

Identifiers

PMID42693924
PMCPMC13588714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.